Christopher E. Cannon

467 total citations
10 papers, 299 citations indexed

About

Christopher E. Cannon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Christopher E. Cannon has authored 10 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in Christopher E. Cannon's work include Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Christopher E. Cannon is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Christopher E. Cannon collaborates with scholars based in United States and Singapore. Christopher E. Cannon's co-authors include Jason M. Uslaner, Scott D. Kuduk, Donnie Eddins, Henry S. Lange, Joshua D. Vardigan, Jeffrey A. Vivian, Marion Wittmann, John J. Renger, Paul J. Coleman and Michelle Pearson and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Psychopharmacology and Neuropharmacology.

In The Last Decade

Christopher E. Cannon

9 papers receiving 295 citations

Peers

Christopher E. Cannon

CMN

PHARM

PMH

Karin Sandager‐Nielsen Denmark

Kristen G. Jordan United States

Kirsten L. Miller United States

Bryan Roth United States

Curt Christoffersen United States

Adeline Cathala France

Oleg I. Barygin Russia

Christopher L. Chio United States

Joshua D. Vardigan United States

Kevin Skoblenick Canada

Karin Sandager‐Nielsen Denmark

Christopher E. Cannon

221 ×0.9

136 ×0.8

CMN

40 ×0.5

PHARM

22 ×0.6

14 ×0.6

PMH

Citations per year, relative to Christopher E. Cannon Christopher E. Cannon (= 1×) peers Karin Sandager‐Nielsen

Countries citing papers authored by Christopher E. Cannon

Since Specialization

Citations

This map shows the geographic impact of Christopher E. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Cannon more than expected).

Fields of papers citing papers by Christopher E. Cannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Cannon. The network helps show where Christopher E. Cannon may publish in the future.

Co-authorship network of co-authors of Christopher E. Cannon

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Cannon. A scholar is included among the top collaborators of Christopher E. Cannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Cannon. Christopher E. Cannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Sawaya, M.R., Gopi K. Kolluru, Armando G. Salinas, et al.. (2025). Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems. Neurotherapeutics. 22(6). e00770–e00770.

Cannon, Christopher E., et al.. (2025). 96-h methamphetamine self-administration elicits striatal dopamine depletion in male and female rats: a model of binge-like use. Psychopharmacology. 243(1). 177–187. 1 indexed citations

Lange, Henry S., et al.. (2021). Effects of a novel M4 muscarinic positive allosteric modulator on behavior and cognitive deficits relevant to Alzheimer's disease and schizophrenia in rhesus monkey. Neuropharmacology. 197. 108754–108754. 17 indexed citations

Lange, Henry S., et al.. (2015). The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 355(3). 442–450. 54 indexed citations

Vardigan, Joshua D., Christopher E. Cannon, Marion Wittmann, et al.. (2014). Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey. Psychopharmacology. 232(11). 1859–1866. 44 indexed citations

Eddins, Donnie, Terence G. Hamill, Christopher E. Cannon, et al.. (2013). The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey. Psychopharmacology. 231(3). 511–519. 27 indexed citations

Smith, Sean M., Jason M. Uslaner, Christopher D. Cox, et al.. (2012). The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Neuropharmacology. 64. 215–223. 70 indexed citations

Cannon, Christopher E., et al.. (2012). The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys. Neuropharmacology. 64. 191–196. 28 indexed citations

Uslaner, Jason M., Donnie Eddins, Christopher E. Cannon, et al.. (2012). The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque. Psychopharmacology. 225(1). 21–30. 57 indexed citations

10.

Cannon, Christopher E. & Sidney C. Smith. (1999). Current therapies for secondary prevention after myocardial infarction. Current Opinion in Cardiology. 14(2). 155–155. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact